Literature DB >> 10921392

Natural history of chronic hepatitis C.

H Yatsuhashi1, M Yano.   

Abstract

The natural history of chronic hepatitis C is one of a slow progression from early stage chronic hepatitis without fibrosis to cirrhosis or hepatocellular carcinoma (HCC). The disease progresses to advanced stage chronic hepatitis C over 10-30 years. Data from Japan indicate that mortality associated with chronic hepatitis C results mainly from the development of HCC. We studied 186 patients referred between 1968 and 1994. The mean follow-up interval was 8.6 (2-23) years. HCC developed in 34 patients (18%). The cumulative probability of HCC development was 4% at 5 years, 18% at 10 years and 45% at 15 years. Univariable analysis indicated that age at entry, fibrosis stage, inflammation activity and the status of IFN treatment (treated vs untreated) were predictive risk factors for developing HCC in patients with chronic hepatitis C. Multivariable analysis of these risk factors indicated that age at entry (> 50 vs < 50; Risk Ratio = 3.2, P< 0.005) and fibrosis stage (F3 vs F0; Risk Ratio= 5.6, P< 0.005) are independent risk factors for HCC. From these results it was concluded that (1) 20% of patients referred to liver clinics with chronic hepatitis C in Japan can be expected to develop HCC over a 10 year period; (2) the risk of HCC increases with progression of liver fibrosis (F3, F4) and age (greater than 50 years old) at the time of diagnosis and (3) the degree of liver fibrosis is a critical predictive factor for the occurrence of HCC.

Entities:  

Mesh:

Year:  2000        PMID: 10921392     DOI: 10.1046/j.1440-1746.2000.02122.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Liver transplantation for hepatocellular carcinoma.

Authors:  A W Hemming; M S Cattral; A I Reed; W J Van Der Werf; P D Greig; R J Howard
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  MR elastography of the liver at 3 T with cine-tagging and bending energy analysis: preliminary results.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Teruhiko Kitagawa; Yuriko Suzuki; Hiroshi Kondo; Satoshi Goshima; Kimihiro Kajita; Kyongtae T Bae; Yoshinobu Hirose; Seiki Miotani; Xiangrong Zhou; Hiroshi Fujita
Journal:  Eur Radiol       Date:  2010-05-04       Impact factor: 5.315

3.  Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.

Authors:  Nestor F Esnaola; Gregory Y Lauwers; Nadeem Q Mirza; David M Nagorney; Dorota Doherty; Iwao Ikai; Yoshio Yamaoka; Jean Marc Regimbeau; Jacques Belghiti; Steven A Curley; Lee M Ellis; J Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 4.  Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance.

Authors:  Katsuhisa Nakatsuka; Masanori Atsukawa; Masumi Shimizu; Hidemi Takahashi; Chiaki Kawamoto
Journal:  World J Hepatol       Date:  2015-11-08

5.  Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.

Authors:  Hirofumi Uto; Seiich Mawatari; Kotaro Kumagai; Akio Ido; Hirohito Tsubouchi
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.